Researchers develop mathematical model to predict effective dosage range of cancer treatment

FHS
May 28, 2024
11:46 am

Cancer poses significant challenges due to the development of resistance and the likelihood of relapse. Resistance may arise from permanent genetic changes in cancer cells or non-genetic alterations in cancer cell behavior induced by treatment.

Opinion | The Heart of Healthcare Innovation Keeps Beating

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

May 14, 2024

Doctors Without Borders rejects ViiV Healthcare’s proposed contract for long-acting HIV PrEP drug

Medical advocacy group Médecins Sans Frontières (MSF), also known as Doctors Without Borders, called upon ViiV Healthcare Thursday to cut a confidentiality clause and revise

August 18, 2023

Innovent Biologics highlights subgroup of lung cancer patients in early-stage study of bispecific

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.